TGINSIGHT SIMILAR POSTS
Изворен канал @pythonotes · Post #418 · 9 мар.
Оператор pipe позволяет писать более компактный код, реализуя логику объединения данных (Union). Важно помнить, что его поведение зависит от контекста. Побитовые операции (логическое OR) result = 5 | 3 # 5 (0101) | 3 (0011) = 7 (0111) Самое главное - не путать с оператором or, это другое! Объединение множеств set_a = {1, 2, 3} set_b = {3, 4, 5} set_c = set_a | set_b # {1, 2, 3, 4, 5} set_c |= {5, 6} # {1, 2, 3, 4, 5, 6} Слияние словарей dict_1 = {"a": 1, "b": 2} dict_2 = {"b": 3, "c": 4} merged = dict_1 | dict_2 # {'a': 1, 'b': 3, 'c': 4} merged |= {"d": 5} # {'a': 1, 'b': 3, 'c': 4, 'd': 5} Аннотации типов, заменяет Union def process_data(value: int | str) -> None: print(value) Допустимо использовать в isinstance или issubclass isinstance(3, int | float) # True Паттерн-матчинг status_code = 404 match status_code: case 200 | 201 | 204: print("OK") case 400 | 404 | 500: print("ERROR") Для использования в своих классах требуется переопределить метод __or__ Так же нашел библиотеку pipe которая добавляет еще много возможностей. Рекомендую ознакомиться ;) #basic
Hashtags
Пребарај: #biotechnology
@venturevillagewall · Post #3500 · 19.12.2024 г., 13:59
Xcell Biosciences Secures $1.4M Xcell Biosciences has raised $1.40 million for advancing its cell therapy manufacturing. The funding round took place on December 17, 2024. Learn more at Xcell Biosciences #XcellBiosciences#Funding#CellTherapy#SanFrancisco#Biotechnology#HealthTech
@venturevillagewall · Post #3574 · 20.12.2024 г., 09:33
Tessera Therapeutics Secures $50M Tessera Therapeutics has raised $50 million in funding on December 18, 2024. The early-stage life sciences company is at the forefront of Gene Writing™, a cutting-edge biotechnology aimed at transforming medicine and scientific research. More details available on their official website: Tessera Therapeutics #TesseraTherapeutics#Funding#LifeSciences#Biotechnology#GeneWriting#Healthcare#MedicalResearch
@venturevillagewall · Post #3627 · 21.12.2024 г., 10:22
First Oral Diabetes Therapy Funded TIXiMED has raised $2.65 million to develop TXNIP inhibiting medication, targeting Type 1 and Type 2 Diabetes with an innovative oral therapeutic. Learn more about their project here. #TIXiMED#Diabetes#Funding#Healthcare#TXNIP#Therapeutics#Type1Diabetes#Type2Diabetes#Biotechnology
@venturevillagewall · Post #3582 · 20.12.2024 г., 09:34
$140M Funding for Ottimo Pharma Ottimo Pharma announces a funding round of $140 million set for December 19, 2024. The company focuses on developing bi-functional medicines aimed at improving the lives of individuals living with cancer. Learn more #Funding#OttimoPharma#Cancer#BiFunctionalMedicines#Healthcare#Pharmaceuticals#LifeSciences#Investments#MedicalResearch#Oncology#HealthTech#Biotechnology
@venturevillagewall · Post #3557 · 20.12.2024 г., 09:32
Spine BioPharma Raises $13.51M Spine BioPharma has successfully closed a funding round totaling $13.51 million, announced on December 18, 2024. For more details, visit their official site: Spine BioPharma. #SpineBioPharma#Funding#BioPharma#Investment#Healthcare#LifeSciences#VentureCapital#Startup#ClinicalTrials#MedicinalResearch#Pharma#Innovations#Tech#Biotechnology#Market#Earnings#Growth#Investors#Equity
@venturevillagewall · Post #3629 · 21.12.2024 г., 10:22
$4.07M Funding for PeptiSystems PeptiSystems secured $4.07M in funding on December 20, 2024. The company develops advanced instruments for solid-phase synthesis in peptide and oligonucleotide therapeutics, catering to both GMP and non-GMP manufacturing. Discover more: PeptiSystems #Funding#PeptiSystems#Therapeutics#Peptides#Oligonucleotides#GMP#Manufacturing#Synthesis#Biotechnology#Pharmaceuticals#MedicalDevices#FlowthroughColumnTechnology#ProcessDevelopment#LifeSciences